Evaluation in man of fenclozic acid (I.C.I. 54,450: Myalex), a new anti-inflamatory agent. II. Clinical trial in patients with rheumatoid arthritis.
D000082:Acetaminophen / Q000627:therapeutic use; D000700:Analgesics / Q000627:therapeutic use*; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000097:blood / Q000188:drug therapy* / Q000503:physiopathology; D001219:Aspartate Aminotransferases / Q000097:blood; D001241:Aspirin / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D005260:Female; D006225:Hand / Q000503:physiopathology; D006801:Humans; D007521:Isocitrate Dehydrogenase / Q000097:blood; D008297:Male; D010919:Placebos; D012459:Salicylates / Q000097:blood; D013844:Thiazoles / Q000009:adverse effects / Q000097:blood / Q000627:therapeutic use*
D000700:Analgesics; D000893:Anti-Inflammatory Agents; D010919:Placebos; D012459:Salicylates; D013844:Thiazoles; D000082:Acetaminophen; D007521:Isocitrate Dehydrogenase; D001219:Aspartate Aminotransferases; D001241:Aspirin